PROGESTERONE
| Brand name | MILPROSA |
|---|---|
| Active ingredient | PROGESTERONE |
| Strength | 1.78GM |
| Dosage form | SYSTEM |
| Route | VAGINAL |
| Modality | Small molecule |
| FDA approval | April 2020 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8580293 | January 2030 | use U-2810 |
| 10548904 | February 2029 | use U-2810 |
| 10537584 | February 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.